Pure Global
NCT06311071

The Predictive Value of Coronary Artery Calcium Score

The Utility of Coronary Artery Calcium Score for the Prediction of Coronary Artery Disease in Patients With Cardiac Symptoms; a Diagnostic Study
Shiraz University of Medical Sciences·ClinicalTrials.gov·diagnostic testCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Coronary Artery Disease
Drug/Device/Intervention
calcium score
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Shiraz University of Medical Sciences
Location
Shiraz, Iran
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2022
End date
Sep 01, 2023
Enrollment
498 participants
Primary outcome

coronary artery disease,coronary calcium score

Summary

In this analytical prospective study 498 patients over 40 years with any cardiovascular
 symptoms and without pre-established coronary artery disease ( CAD) were enrolled. Patients
 underwent CT scans to measure coronary artery calcium score (CACS), and total calcium scores
 were recorded. Then, conventional coronary angiography was performed for all the participants
 as the gold standard for diagnosing CAD (defined as at least one stenotic coronary artery
 with ≥ 50%). Framingham risk score (FRS) was also estimated for all the patients

ICD-10 classifications
Cardiovascular disease, unspecifiedAtherosclerotic cardiovascular disease, so describedAtherosclerotic heart diseaseAbnormal findings on diagnostic imaging of heart and coronary circulationCoronary vasodilators, not elsewhere classified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06311071
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06311071 through Pure Global AI's free database. This phase not specified trial is sponsored by Shiraz University of Medical Sciences and is currently Completed. The study focuses on Coronary Artery Disease. Target enrollment is 498 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.